547 related articles for article (PubMed ID: 31340969)
21. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon.
Aminde LN; Tindong M; Ngwasiri CA; Aminde JA; Njim T; Fondong AA; Takah NF
BMC Endocr Disord; 2019 Apr; 19(1):35. PubMed ID: 30943969
[TBL] [Abstract][Full Text] [Related]
22. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia.
Balasubramaniam S; Lim SL; Goh LH; Subramaniam S; Tangiisuran B
Diabetes Metab Syndr; 2019; 13(4):2585-2591. PubMed ID: 31405680
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of antidiabetic medication adherence in the Lebanese population: development of the Lebanese Diabetes Medication Adherence Scale.
Ayoub D; Mroueh L; El-Hajj M; Awada S; Rachidi S; Zein S; Al-Hajje A
Int J Pharm Pract; 2019 Oct; 27(5):468-476. PubMed ID: 31264750
[TBL] [Abstract][Full Text] [Related]
25. Medication Adherence and Its Associated Factors among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers of Eastern Province, Saudi Arabia.
Alsaidan AA; Alotaibi SF; Thirunavukkarasu A; ALruwaili BF; Alharbi RH; Arnous MM; Alsaidan OA; Alduraywish AS; Alwushayh YA
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241220
[TBL] [Abstract][Full Text] [Related]
26. Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients.
Wong MC; Wu CH; Wang HH; Li HW; Hui EM; Lam AT; Chung RY; Yip BH; Morisky DE
J Clin Pharmacol; 2015 Mar; 55(3):279-87. PubMed ID: 25293349
[TBL] [Abstract][Full Text] [Related]
27. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus.
Raum E; Krämer HU; Rüter G; Rothenbacher D; Rosemann T; Szecsenyi J; Brenner H
Diabetes Res Clin Pract; 2012 Sep; 97(3):377-84. PubMed ID: 22763108
[TBL] [Abstract][Full Text] [Related]
28. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
29. Medication adherence may be more important than other behaviours for optimizing glycaemic control among low-income adults.
Osborn CY; Mayberry LS; Kim JM
J Clin Pharm Ther; 2016 Jun; 41(3):256-9. PubMed ID: 26939721
[TBL] [Abstract][Full Text] [Related]
30. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study.
Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T
Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004
[TBL] [Abstract][Full Text] [Related]
31. Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China.
Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Chu J; Li L
BMJ Open; 2018 Mar; 8(3):e019697. PubMed ID: 29581203
[TBL] [Abstract][Full Text] [Related]
32. Effect of patient characteristics on medication adherence among patients with type 2 diabetes mellitus: a cross-sectional survey.
Abdullah NF; Khuan L; Theng CA; Sowtali SN; Juni MH
Contemp Nurse; 2019 Feb; 55(1):27-37. PubMed ID: 30764733
[No Abstract] [Full Text] [Related]
33. Adherence to newer second-line oral antidiabetic drugs among people with type 2 diabetes-A systematic review.
Holdt-Caspersen NS; Dethlefsen C; Vestergaard P; Hejlesen O; Hangaard S; Jensen MH
Pharmacol Res Perspect; 2024 Apr; 12(2):e1185. PubMed ID: 38450950
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
Batais MA; Schantter P
Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
[TBL] [Abstract][Full Text] [Related]
35. Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?
Long JA; Wang A; Medvedeva EL; Eisen SV; Gordon AJ; Kreyenbuhl J; Marcus SC
Diabetes Care; 2014 Aug; 37(8):2261-7. PubMed ID: 24879839
[TBL] [Abstract][Full Text] [Related]
36. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
37. Patient and physician factors associated with adherence to diabetes medications.
Schoenthaler AM; Schwartz BS; Wood C; Stewart WF
Diabetes Educ; 2012; 38(3):397-408. PubMed ID: 22446035
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
Aikens JE; Piette JD
Diabet Med; 2013 Mar; 30(3):338-44. PubMed ID: 23075262
[TBL] [Abstract][Full Text] [Related]
39. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
[TBL] [Abstract][Full Text] [Related]
40. Venue of receiving diabetes self-management education and training and its impact on oral diabetic medication adherence.
Wu J; Davis-Ajami ML; Noxon V; Lu ZK
Prim Care Diabetes; 2017 Apr; 11(2):162-170. PubMed ID: 27840086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
